MAIA Biotechnology | Investor Presentation Deck | 31 slides · page 3 of 31
The slide outlines the status of THIO-101, 102, and 103, highlighting FDA designations and clinical trial progress.
Pitch deck · executive_summary · summarize · balanced density
Slide locked Sign in to view
Slide schematic 3/3
image 1/1 list 1/1 title 1/1
Components 3
photo bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.